Toth Financial Advisory Corp Decreases Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Toth Financial Advisory Corp reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 6.2% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 39,271 shares of the financial services provider’s stock after selling 2,591 shares during the period. Toth Financial Advisory Corp’s holdings in iShares Biotechnology ETF were worth $5,192,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in IBB. PVG Asset Management Corp purchased a new position in iShares Biotechnology ETF during the second quarter worth $415,000. Huntington National Bank boosted its stake in shares of iShares Biotechnology ETF by 17.9% during the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock worth $153,000 after purchasing an additional 160 shares during the period. National Bank of Canada FI grew its holdings in iShares Biotechnology ETF by 5.9% during the 3rd quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock valued at $600,000 after purchasing an additional 229 shares during the last quarter. First Financial Bank Trust Division purchased a new stake in iShares Biotechnology ETF in the 3rd quarter worth about $204,000. Finally, Thrive Wealth Management LLC bought a new stake in iShares Biotechnology ETF in the third quarter worth about $445,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Down 0.7 %

IBB opened at $137.30 on Friday. The stock’s 50 day moving average price is $136.04 and its 200-day moving average price is $141.78. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.